These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


362 related items for PubMed ID: 19910286

  • 21. [Drug and electrical therapy of supraventricular tachyarrhythmias].
    Heisel A, Jung J, Schieffer H.
    Z Kardiol; 2000; 89 Suppl 3():68-74. PubMed ID: 10810788
    [Abstract] [Full Text] [Related]

  • 22. Hybrid therapy of atrial fibrillation.
    Santini M, Pignalberi C, Ricci R, Calò L.
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Facilitating electrical cardioversion of persistant atrial fibrillation by antiarrhythmic drugs: update on clinical trial results.
    Sung RJ.
    Card Electrophysiol Rev; 2003 Sep; 7(3):300-3. PubMed ID: 14739733
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
    Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A.
    Heart; 2002 May; 87(5):443-8. PubMed ID: 11997417
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
    Tieleman RG, Van Gelder IC, Bosker HA, Kingma T, Wilde AA, Kirchhof CJ, Bennekers JH, Bracke FA, Veeger NJ, Haaksma J, Allessie MA, Crijns HJ.
    Heart Rhythm; 2005 Mar; 2(3):223-30. PubMed ID: 15851308
    [Abstract] [Full Text] [Related]

  • 31. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department.
    Stiell IG, Macle L, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Mar; 27(1):38-46. PubMed ID: 21329861
    [Abstract] [Full Text] [Related]

  • 32. Dronedarone: an emerging therapy for atrial fibrillation.
    Rosei EA, Salvetti M.
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
    [Abstract] [Full Text] [Related]

  • 33. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN, Tang XC, Reda D, Singh BN.
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
    Kosior D, Szulc M, Zawadzka M, Pierścińska M, Stawicki S, Rabczenko D, Torbicki A, Opolski G.
    Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
    [Abstract] [Full Text] [Related]

  • 37. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C, Valembois L, Bergmann JF, Belmin J.
    Cochrane Database Syst Rev; 2015 Mar 28; (3):CD005049. PubMed ID: 25820938
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
    Humphries KH, Kerr CR, Steinbuch M, Dorian P, Canadian Registry of Atrial Fibrillation investigators.
    CMAJ; 2004 Sep 28; 171(7):741-5. PubMed ID: 15451836
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.